| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Masahiro Yura, Kazuo Koyanagi, Asuka Hara, Keita Hayashi, Yuki Tajima, Yasushi Kaneko, Hiroto Fujisaki, Akira Hirata, Kiminori Takano, Kumiko Hongo, Kikuo Yo, Kimiyasu Yoneyama, Yoshifumi Tamai, Reiko Dehari and Motohito Nakagawa |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Masahiro Yura, MD, Doctor, Doctor, Surgeon, Department of Surgery, Hiratsuka City Hospital, 1-19-1, Minamihara, Hiratsuka-shi, Kanagawa 2540065, Japan. myura@ncc.go.jp |
| Key Words |
Unresectable esophageal cancer; Induction docetaxel, cisplatin and fluorouracil; Chemoradiotherapy; Complete response; Additional chemotherapy; Case report |
| Core Tip |
Salvage surgery after definitive chemoradiotherapy (dCRT) for T4 esophageal cancer is associated with a high incidence of surgery-related death and severe complication. In the present study, we have described the successful case of an unresectable locally advanced T4 esophageal squamous cell carcinoma treated by additional cisplatin plus 5 fluorouracil chemotherapy after induction docetaxel, cisplatin and fluorouracil followed by dCRT. This case suggests that additional cisplatin plus 5 fluorouracil chemotherapy could be one radical treatment option for residual esophageal squamous cell carcinoma after induction docetaxel, cisplatin and fluorouracil followed by dCRT to avoid salvage surgery, especially for high-risk patients. |
| Publish Date |
2021-04-15 04:26 |
| Citation |
Yura M, Koyanagi K, Hara A, Hayashi K, Tajima Y, Kaneko Y, Fujisaki H, Hirata A, Takano K, Hongo K, Yo K, Yoneyama K, Tamai Y, Dehari R, Nakagawa M. Unresectable esophageal cancer treated with multiple chemotherapies in combination with chemoradiotherapy: A case report. World J Clin Cases 2021; 9(12): 2801-2810 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i12/2801.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i12.2801 |
